Metraipolis › archive › dc_6ed320104083
Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation — Europe PMC PMID:41737939
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41737939
- DOI
- 10.1016/j.hroo.2025.11.019
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T02:35:08.617Z
- SHA-256 of the archived text
11df24da123ac6905ad01ac883d3048664b33a11ae5383e86126244f7f2652db- Stable URL of this page
https://metraipolis.com/documento/dc_6ed320104083
How to cite
Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation — Europe PMC PMID:41737939 — Europe PMC (en), https://europepmc.org/article/MED/41737939 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ed320104083 (Metraipolis archive dc_6ed320104083, sha256 11df24da123ac6905ad01ac883d3048664b33a11ae5383e86126244f7f2652db)
BibTeX
@misc{dc6ed320104083,
title = {Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation — Europe PMC PMID:41737939},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41737939},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ed320104083; sha256 11df24da123ac6905ad01ac883d3048664b33a11ae5383e86126244f7f2652db},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737939. Agents can read the archived copy with the MCP tool read_document.